REGINA DOHERTY: Open Payments
NPI 1972041630 · WHIPPANY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 26 payments from 11 companies in 2025. Trend: 2023 $570 · 2024 $1,159 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | 3 | $178 |
| COLOPLAST CORP | 1 | $104 |
| TOLMAR, INC. | 5 | $90 |
| ABBVIE INC. | 4 | $70 |
| PFIZER INC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Antares Pharma, Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Tempus AI, Inc | 1 | $24 |
| AXOGEN | 1 | $21 |
Products named: PYLARIFY, Titan, JATENZO, PLUVICTO, XTANDI, ELIGARD, XYOSTED, LUPRON DEPOT.
Industry payments across NJ — which companies pay providers there.
